Patents by Inventor Concetta Bubici

Concetta Bubici has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IDENTIFICATION OF NOVEL FACTORS THAT BLOCK PROGRAMMED CELL DEATH OR APOPTOSIS BY TARGETING JNK
    Publication number: 20080247956
    Abstract: Methods and compositions for modulating apoptosis by acting on the c-Jun-N-terminal kinase (JNK) pathway and assays for the isolation of agents capable of modulating apoptosis, including modulators of the JNK pathway are disclosed. A method of modulating JNK pathway independent of Gadd46? is disclosed. Methods and compositions are presented for the preparation and use of novel therapeutic compositions for modulating diseases and conditions associated with elevated or decreased apoptosis.
    Type: Application
    Filed: February 13, 2008
    Publication date: October 9, 2008
    Applicant: THE UNIVERSITY OF CHICAGO
    Inventors: Guido Franzoso, Salvatore Papa, Concetta Bubici, Francesca Zazzeroni
  • Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
    Patent number: 7354898
    Abstract: Methods and compositions for modulating apoptosis by acting on the c-Jun-N-terminal kinase (JNK) pathway and assays for the isolation of agents capable of modulating apoptosis, including modulators of the JNK pathway are disclosed. A method of modulating JNK pathway independent of Gadd46? is disclosed. Methods and compositions are presented for the preparation and use of novel therapeutic compositions for modulating diseases and conditions associated with elevated or decreased apoptosis.
    Type: Grant
    Filed: January 10, 2005
    Date of Patent: April 8, 2008
    Assignee: University of Chicago
    Inventors: Guido Franzoso, Salvatore Papa, Concetta Bubici, Francesca Zazzeroni
  • Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
    Patent number: 7326418
    Abstract: Methods and compositions for modulating apoptosis by acting on the c-Jun-N-terminal kinase (JNK) pathway and assays for the isolation of agents capable of modulating apoptosis, including modulators of the JNK pathway are disclosed. A method of modulating JNK pathway independent of Gadd46? is disclosed. Methods and compositions are presented for the preparation and use of novel therapeutic compositions for modulating diseases and conditions associated with elevated or decreased apoptosis.
    Type: Grant
    Filed: November 29, 2004
    Date of Patent: February 5, 2008
    Assignee: University of Chicago
    Inventors: Guido Franzoso, Salvatore Papa, Concetta Bubici, Francesca Zazzeroni
  • Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
    Publication number: 20050265970
    Abstract: Methods and compositions for modulating apoptosis by acting on the c-Jun-N-terminal kinase (JNK) pathway and assays for the isolation of agents capable of modulating apoptosis, including modulators of the JNK pathway are disclosed. A method of modulating JNK pathway independent of Gadd46? is disclosed. Methods and compositions are presented for the preparation and use of novel therapeutic compositions for modulating diseases and conditions associated with elevated or decreased apoptosis.
    Type: Application
    Filed: January 10, 2005
    Publication date: December 1, 2005
    Inventors: Guido Franzoso, Salvatore Papa, Concetta Bubici, Francesca Zazzeroni
  • Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
    Publication number: 20050267022
    Abstract: Methods and compositions for modulating apoptosis by acting on the c-Jun-N-terminal kinase (JNK) pathway and assays for the isolation of agents capable of modulating apoptosis, including modulators of the JNK pathway are disclosed. A method of modulating JNK pathway independent of Gadd46? is disclosed. Methods and compositions are presented for the preparation and use of novel therapeutic compositions for modulating diseases and conditions associated with elevated or decreased apoptosis.
    Type: Application
    Filed: November 29, 2004
    Publication date: December 1, 2005
    Inventors: Guido Franzoso, Salvatore Papa, Concetta Bubici, Francesca Zazzeroni